Following the delivery of a net profit of 36.284 billion yuan for 2025, representing a 38.3% year-on-year increase, New China Life Insurance Company Ltd. (ASX: NCI) has received a new round of director nominations from its largest shareholder, Central Huijin Investment Ltd.
The insurer announced on the evening of June 10th that its board of directors had reviewed and unanimously approved the nomination of Huang Geng as a candidate for non-executive director of the ninth board of directors. This proposal will be submitted to the annual shareholders' meeting for deliberation. If approved by the shareholders' meeting, Huang Geng's appointment will still require final approval from the regulatory authorities.
According to an H-share announcement disclosed on the same day, this nomination was put forward by Central Huijin Investment Ltd., the largest shareholder of New China Life Insurance Company Ltd. (ASX: NCI), holding a 31.34% stake.
Extensive Background in Financial Regulation
Huang Geng was born in January 1975 and obtained a bachelor's degree in accounting from Jinan University in July 2000. His career began at the Guangzhou branch of the People's Bank of China, after which he transitioned into the insurance regulatory system, where he has worked for over two decades.
Starting in October 2000, Huang held various positions including assistant section member, deputy section chief, and section chief within the audit and inspection department of the former China Insurance Regulatory Commission's (CIRC) Guangzhou office and later the Guangdong bureau.
After moving to Beijing in September 2004, he served in the former CIRC's property insurance supervision department, progressing from a staff member to roles such as deputy director and director of various divisions, including the risk analysis division.
Following the establishment of the National Financial Regulatory Administration, Huang Geng was appointed as director and second-level inspector of the property insurance supervision divisions within the administration's property and reinsurance supervision department. He currently serves as the director of one of these divisions.
No Director Compensation if Appointed
The announcement also stated that if Huang Geng assumes the position, he will not receive any director remuneration or other compensation from the company in his capacity as a non-executive director. His term would commence upon regulatory approval and last until the expiration of the ninth board's term.
His resume indicates that, as of the announcement date, Huang Geng does not hold any shares of New China Life Insurance Company Ltd. (ASX: NCI). He has no relationship with the company's directors, senior management, major shareholders, or controlling shareholders, and has not been subject to any penalties from regulatory bodies.
Central Huijin as the Controlling Shareholder
Central Huijin Investment Ltd., which nominated Huang Geng, is the largest shareholder of New China Life Insurance Company Ltd. (ASX: NCI). It acquired a 38% stake in the insurer in 2009, which was transferred from the insurance security fund.
Central Huijin is a state-owned sole proprietorship company established with state capital. Authorized by the State Council, it makes equity investments in key state-owned financial enterprises. It represents the state in exercising investor rights and fulfilling obligations for these enterprises, aiming to preserve and increase the value of state-owned financial assets. It does not engage in other commercial activities or intervene in the daily operations of the financial firms it controls.
In 2007, all its equity was injected into China Investment Corporation. As of the end of 2025, Central Huijin holds controlling or significant stakes in over twenty key financial institutions.
Governance Implications of the New Nomination
The ninth board of New China Life Insurance Company Ltd. (ASX: NCI) originally consisted of one chairman, one executive director, four independent directors, and four non-executive directors. The non-executive director seats were equally split between representatives from the largest shareholder, Central Huijin, and the second-largest shareholder.
The addition of one more non-executive director nominated by Central Huijin will increase its representation on the board. This move is expected to further enhance the board's governance capabilities.
Against the backdrop of New China Life Insurance Company Ltd.'s (ASX: NCI) recently announced strong 2025 financial results, the proposed addition of a new director candidate with deep regulatory experience is anticipated to bring a professional perspective to the company's governance.
Comments